In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
Opinion: Comparing Coronaviruses
Opinion: Comparing Coronaviruses
In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
Some children who experience the severe inflammatory condition after COVID-19 may continue to experience milder problems such as muscle weakness or anxiety even after that period, according to a small observational study in the UK.
Two studies this month point to pooches’ quick detection of SARS-CoV-2 on material that touched the skin of infected participants, although the pups’ accuracy does not match that of RT-PCR.
Countries outside the US and Europe that are already used to long wait times for laboratory supplies are facing greater research disruptions than ever during the pandemic.
A letter signed by 18 researchers argues that hypotheses about zoonotic spillover or accidental lab release both “remain viable” in the absence of additional evidence.
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
A modeling study of boarding behavior finds filling the plane from back to front extends the close contact time between passengers and therefore increases the risks posed by air travel.
Following vaccination, some women claim their periods have changed, leading to rumors about how the shots affect recipients’ reproductive systems, and even others’ by proxy.
Scientists at the US CDC report no red flags in a preliminary analysis of the safety of Pfizer/BioNTech’s and Moderna’s mRNA-based immunizations among expectant mothers.
It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
In the armpit lymph nodes of people who had received the mRNA vaccine against SARS-CoV-2, researchers found germinal centers needed to generate long-lived antibody-making cells.
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.